Schrödinger, Inc. (SDGR)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS80810D1037
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Schrödinger, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:45. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 16:00 | -0.07 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.67 | -0.50 | +25.0% | Beat |
| 05 Aug 2026 16:00 | -0.67 | -0.42 | +37.9% | Beat |
| 05 May 2026 16:00 | -0.57 | -0.62 | -9.0% | Miss |
| 25 Feb 2026 16:00 | -0.09 | -0.18 | -100.2% | Miss |
| 05 Nov 2025 16:00 | -0.74 | -0.57 | +23.0% | Beat |
| 06 Aug 2025 16:00 | -0.64 | -0.65 | -1.6% | Miss |
| 07 May 2025 16:00 | -0.81 | -0.64 | +21.0% | Beat |
| 26 Feb 2025 16:00 | -0.38 | -0.24 | +36.8% | Beat |
| 12 Nov 2024 06:00 | -0.63 | -0.87 | -38.1% | Miss |
| 31 Jul 2024 16:00 | -0.89 | -0.74 | +16.6% | Beat |
| 01 May 2024 16:00 | -0.74 | -0.76 | -2.7% | Miss |
| 28 Feb 2024 16:00 | -0.36 | -0.31 | +13.7% | Beat |
| 01 Nov 2023 16:00 | -0.69 | -0.70 | -1.5% | Miss |
| 02 Aug 2023 16:00 | -0.38 | -0.60 | -57.9% | Miss |
| 04 May 2023 16:00 | -0.19 | -0.23 | -22.9% | Miss |
| 28 Feb 2023 16:00 | -0.46 | -0.22 | +51.9% | Beat |
| 03 Nov 2022 16:00 | -0.59 | -0.50 | +16.0% | Beat |
| 04 Aug 2022 16:00 | -0.49 | -0.17 | +64.3% | Beat |
| 04 May 2022 16:00 | -0.43 | -0.27 | +37.4% | Beat |
| 24 Feb 2022 16:00 | -0.32 | -0.22 | +32.5% | Beat |
| 10 Nov 2021 16:00 | -0.29 | -0.38 | -30.2% | Miss |
| 12 Aug 2021 07:00 | -0.09 | -0.32 | -257.6% | Miss |
| 11 May 2021 07:00 | -0.25 | -0.27 | -6.8% | Miss |
| 04 Mar 2021 07:00 | -0.13 | -0.21 | -59.6% | Miss |
| 12 Nov 2020 07:00 | -0.09 | -0.22 | -128.2% | Miss |
| 10 Aug 2020 06:00 | -0.32 | -0.25 | +23.5% | Beat |
| 13 May 2020 07:00 | -0.20 | -0.22 | -10.3% | Miss |
| 16 Mar 2020 16:00 | -0.68 | -3.69 | -438.7% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 255.9M | +23.3% | -103.3M | -40.4% | -1.41 | +45.1% | 12.5M |
| 2024 | 207.5M | -4.2% | -187.1M | -90.2% | -2.57 | -575.9% | -164.7M |
| 2023 | 216.7M | +19.7% | 40.7M | 18.8% | 0.54 | +125.7% | -150.1M |
| 2022 | 181M | — | -149.2M | -82.4% | -2.10 | — | -127.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 27.76 | 34.00 | 25.93 | 29.13 | +7.31% | 16,800,451 | |
| Oct 2026 | 30.77 | 33.78 | 21.73 | 27.14 | -12.59% | 53,671,300 | |
| Sep 2026 | 19.25 | 32.45 | 18.63 | 31.05 | +59.23% | 49,857,900 | |
| Aug 2026 | 15.14 | 20.48 | 14.91 | 19.50 | +28.80% | 24,274,700 | |
| Jul 2026 | 16.42 | 17.63 | 14.61 | 15.14 | -6.83% | 21,384,100 | |
| Jun 2026 | 15.23 | 17.82 | 13.90 | 16.25 | +6.91% | 32,252,600 | |
| May 2026 | 12.17 | 15.44 | 11.56 | 15.20 | +27.09% | 28,160,800 | |
| Apr 2026 | 11.53 | 13.31 | 11.02 | 11.96 | +5.28% | 30,805,200 | |
| Mar 2026 | 11.64 | 13.21 | 10.95 | 11.36 | -5.80% | 24,313,200 | |
| Feb 2026 | 13.88 | 14.43 | 11.11 | 12.06 | -13.67% | 34,151,500 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Schrödinger, Inc. (SDGR) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 12:51
- Is Schrödinger (SDGR) Still Below Fair Value After Strong Q3 Revenue Growth? (opens in a new tab) Simply Wall St. · 08 Nov 2026 00:20
- Raised Guidance Could Change The Case For Schrödinger Stock (SDGR) (opens in a new tab) Simply Wall St. · 07 Nov 2026 20:12
- Schrödinger, Inc. (SDGR) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 05:45
- Schrodinger Inc (SDGR) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong ACV ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 05:17
- What Schrodinger (SDGR) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 05 Nov 2026 04:14
- Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
- Schrödinger (SDGR) Stock Sees Fair Value Lift As AI Optimism Lifts Analyst Targets (opens in a new tab) Simply Wall St. · 29 Oct 2026 00:19
- Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline (opens in a new tab) Zacks · 28 Oct 2026 13:00
- Schrödinger (SDGR) Stock Fair Value Edges Higher As Analyst Views Split On AI Growth (opens in a new tab) Simply Wall St. · 14 Oct 2026 03:13
- Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? (opens in a new tab) Zacks · 06 Oct 2026 11:38
- Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View (opens in a new tab) Simply Wall St. · 27 Sep 2026 21:05
- Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs (opens in a new tab) Barchart · 23 Sep 2026 18:50
- Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock? (opens in a new tab) Zacks · 16 Sep 2026 11:51
- 4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma (opens in a new tab) Zacks · 17 Aug 2026 14:56
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 30.85 USD
- Market cap
- 2.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 20.4 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 5.5 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.5 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 5.6 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -24.01× | Weak | 14.16× |
| Price / book | 8.06× | Weak | 3.5× |
| Price / sales | 9.01× | Weak | 3.33× |
| EV / EBITDA | -17× | Weak | 11.19× |
| Free cash flow yield | -1.4% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 58.5% | Good | 54.9% |
| Operating margin | -40.5% | Weak | 5.8% |
| Net margin | -22% | Weak | 1.2% |
| Return on equity | -19% | Weak | 4.4% |
| Return on assets | -13.2% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 12.2% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.35× | Good | 0.4× |
| Current ratio | 2.75× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow SDGR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.